Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Niels van Royen Added: 1 year ago
Prof Niels van Royen(Radboud University Medical Center, NL) presentsThe Role of the Wearable Cardioverter Defibrillator in the Prevention of Sudden Cardiac Deathfrom NVVC Najaarscongres 2022. View more
Author(s): Angelo Auricchio , Anne B Curtis Added: 1 year ago
Prof Anne Curtis (University of Buffalo, US) and Prof Angelo Auricchio (Fondazione Cardiocentro Ticino, CH) discuss contemporary clinical data of Implantable Cardioverter Defibrillators (ICDs) from real world populations. The discussion is focused on the importance and impact of ICD therapy on prevention of sudden cardiac death by analysing the latest presented data.In context, the data analysed… View more
Author(s): Luca Santini Added: 1 year ago
Dr Luca Santini (G. B. GRASSI Hospital, Italy) focused on the role of the wearable cardioverter defibrillator (WCD) during the high-risk phase in HF-patients. He concludes that the high-risk phase of HF poses a considerable threat of SCD, necessitating temporary protection strategies. A WCD can offer a valuable solution by providing continuous monitoring and the ability to deliver life-saving… View more
Author(s): Lucas Boersma , Stefan Winter Added: 1 year ago
Join Prof Lucas Boersma and Dr Stefan Winter at NVVC-NVT 2023 in this symposium on 'Prevention of Sudden Cardiac Death in Newly Diagnosed Heart Failure Patients and the Role of the Wearable Cardioverter Defibrillator (WCD)'. View more
Added: 1 year ago Source:  Radcliffe Cardiology
AUTHOR: Brad WilsonRAFT, a new extended follow-up trial (NCT00251251) showed insight into the survival benefit associated with coronary resynchronization therapy defibrillator (CRT-D) as compared to implantable cardioverter-defibrillator (ICD) in patients with heart failure.Methodology:The Resynchronization/Defibrillation for Ambulatory Heart Failure Trial (RAFT) is a randomized trial which aimed… View more
Research Area(s) / Expertise:

Atrial Arrhythmias

Pacing, Defibrillators & Cardiac Resynchronisation Therapy

Electrophysiology & Arrhythmia

Job title: Cardiac Electrophysiologist
DrHafiza Khan is a Cardiac Electrophysiologist at Baylor Scott & White Arrhythmia Management. She is a graduate of UCLA School of Medicine, Board Certified in both Cardiovascular disease as well as Electrophysiology, and has been in practice for over 18 years. In addition to performing catheter ablation for cardiac arrhythmias, implantation of pacemakersand implantable cardiac defibrillators,… View more
Research Area(s) / Expertise:
Author of more than 120 scientific communications (of which more than 50 in International Congresses). Author of more than 20 articles published, most in International journals Associate investigator of multiple multicentre clinical trials and national and international registries Assistant of the course of Introduction to the Clinic (3rd year, Faculty of Medicine of Lisbon). Professor and… View more
Added: 1 month ago Source:  Heart Rhythm 2025
Heart Rhythm 2025 has released its program featuring five late-breaking clinical trials and science sessions which will take place from the 25th to 27thApril. The meeting is located in San Diego Convention Center, California. Access the full programme here.Late-Breaking Clinical Trials and Science: Clinical Trials Updates and RegistriesFriday 25th April, 11:45 – 12:45pm (PDT)A Multielectrode… View more